Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obstetric thromboprophylaxis

C Nelson-Piercy1

  • 1Institute of Obstetrics and Gynaecology, Queen Charlotte's Hospital, London.

British Journal of Hospital Medicine
|April 3, 1996
PubMed
Summary
This summary is machine-generated.

Pregnancy and caesarean sections significantly raise the risk of thromboembolism, a leading cause of maternal death. This review covers risk factors, medications, and prophylaxis guidelines for preventing blood clots during pregnancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful spinal anaesthesia for caesarean birth after epidural blood patch for intracranial hypotension headache.

Anaesthesia reports·2025
Same author

Approach to dyspnoea in pregnancy in the COVID-19 era.

Acute medicine·2020
Same author

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update.

The British journal of dermatology·2020
Same author

Is it time to screen for cardiometabolic risk factors prior to ART?

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Transplacental metoprolol for fetal supraventricular tachycardia.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2019
Same author

Clinical management of nausea and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a population-based study.

BJOG : an international journal of obstetrics and gynaecology·2019
Same journal

The autopsy in the 1990s.

British journal of hospital medicine·1999
Same journal

Screening for breast cancer.

British journal of hospital medicine·1999
Same journal

Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

British journal of hospital medicine·1999
Same journal

Liposarcoma: a review of current diagnosis and management.

British journal of hospital medicine·1999
Same journal

How to do it in surgery: laparoscopic rectopexy.

British journal of hospital medicine·1999
Same journal

The management of ovarian cancer.

British journal of hospital medicine·1999
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Maternal Health

Background:

  • Thromboembolism represents a significant cause of mortality in pregnant individuals.
  • Pregnancy, especially following caesarean section, is associated with an elevated risk of thrombosis.
  • Understanding these risks is crucial for effective maternal care.

Purpose of the Study:

  • To review the primary risk factors for thromboembolism in pregnancy.
  • To discuss the pharmacological agents available for thromboembolism prophylaxis.
  • To outline the established indications for preventative treatment in pregnant patients.

Main Methods:

  • Literature review of existing studies and guidelines on thromboembolism in pregnancy.
  • Synthesis of information regarding risk assessment and stratification.

Related Experiment Videos

  • Analysis of current therapeutic options for prophylaxis.

    • Main Results:

    • Identified key risk factors including mode of delivery, pre-existing conditions, and immobility.
    • Summarized commonly used anticoagulant drugs for prophylaxis.
    • Detailed indications for initiating prophylactic measures based on individual patient risk.

    Conclusions:

    • Thromboembolism prophylaxis in pregnancy requires careful consideration of individual risk factors.
    • Appropriate pharmacological interventions can mitigate the risk of maternal mortality associated with thrombosis.
    • Adherence to established guidelines ensures optimal patient outcomes.